Lam Alan T L, Reuveny Shaul, Oh Steve Kah-Weng
Bioprocessing Technology Institute, A*STAR (Agency for Science, Technology and Research), Singapore 138668, Singapore.
Bioprocessing Technology Institute, A*STAR (Agency for Science, Technology and Research), Singapore 138668, Singapore.
Stem Cell Res. 2020 Apr;44:101738. doi: 10.1016/j.scr.2020.101738. Epub 2020 Feb 18.
Articular cartilage defects are one of the major challenges in orthopedic and trauma surgery. However, the poor ability of cartilage to self-repair has motivated efforts to engineer replacement tissues, and human mesenchymal stem cells (MSC), which have an extensive proliferation potential and can undergo chondrogenesis, have emerged as a promising cell source. In this review, we attempt to provide a brief overview of MSC isolation, characterization, current manufacturing platforms using various bioreactors, in vitro differentiation, and sealant-based or scaffold-based implantation.
关节软骨缺损是骨科和创伤外科面临的主要挑战之一。然而,软骨自身修复能力较差,促使人们努力构建替代组织,而具有广泛增殖潜力且能发生软骨形成的人间充质干细胞(MSC)已成为一种有前景的细胞来源。在本综述中,我们试图简要概述MSC的分离、特性、使用各种生物反应器的当前制造平台、体外分化以及基于密封剂或基于支架的植入。